Loading...

Zvavahera Chirenje, MD

TitleAcademic Coordinator III
SchoolUCSF School of Medicine
DepartmentOb/Gyn, Reproductive Sciences
AddressSan Francisco CA
Phone263-470-4890
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Koss CA, Bacchetti P, Hillier SL, Livant E, Horng H, Mgodi N, Mirembe BG, Gomez Feliciano K, Horn S, Liu AY, Glidden DV, Grant RM, Benet LZ, Louie A, van der Straten A, Chirenje Z, Marrazzo JM, Gandhi M. Differences in Cumulative Exposure and Adherence to Tenofovir in the VOICE, iPrEx OLE, and PrEP Demo Studies as Determined via Hair Concentrations. AIDS Res Hum Retroviruses. 2017 Mar 02. PMID: 28253024.
      View in: PubMed
    2. Samaneka WP, Mandozana G, Tinago W, Nhando N, Mgodi NM, Bwakura-Dangarembizi MF, Munjoma MW, Gomo ZA, Chirenje Z, Hakim JG. Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population. PLoS One. 2016; 11(11):e0165821. PMID: 27812172.
      View in: PubMed
    3. Mensch BS, Brown ER, Liu K, Marrazzo J, Chirenje Z, Gomez K, Piper J, Patterson K, van der Straten A. Reporting of Adherence in the VOICE Trial: Did Disclosure of Product Nonuse Increase at the Termination Visit? AIDS Behav. 2016 Nov; 20(11):2654-2661. PMID: 26906023.
      View in: PubMed
    4. Balkus JE, Brown E, Palanee T, Nair G, Gafoor Z, Zhang J, Richardson BA, Chirenje Z, Marrazzo JM, Baeten JM. An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women. J Acquir Immune Defic Syndr. 2016 Jul 1; 72(3):333-43. PMID: 26918545.
      View in: PubMed
    5. Mirembe BG, Kelly CW, Mgodi N, Greenspan S, Dai JY, Mayo A, Piper J, Akello CA, Kiweewa FM, Magure T, Nakabiito C, Marrazzo JM, Chirenje Z, Riddler SA. Bone Mineral Density Changes Among Young, Healthy African Women Receiving Oral Tenofovir for HIV Preexposure Prophylaxis. J Acquir Immune Defic Syndr. 2016 Mar 1; 71(3):287-94. PMID: 26866954.
      View in: PubMed
    6. Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, Mgodi NM, Matovu Kiweewa F, Nair G, Mhlanga F, Siva S, Bekker LG, Jeenarain N, Gaffoor Z, Martinson F, Makanani B, Pather A, Naidoo L, Husnik M, Richardson BA, Parikh UM, Mellors JW, Marzinke MA, Hendrix CW, van der Straten A, Ramjee G, Chirenje Z, Nakabiito C, Taha TE, Jones J, Mayo A, Scheckter R, Berthiaume J, Livant E, Jacobson C, Ndase P, White R, Patterson K, Germuga D, Galaska B, Bunge K, Singh D, Szydlo DW, Montgomery ET, Mensch BS, Torjesen K, Grossman CI, Chakhtoura N, Nel A, Rosenberg Z, McGowan I, Hillier S. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med. 2016 Feb 22. PMID: 26900902.
      View in: PubMed
    7. Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje Z. Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial. Contraception. 2016 Jan; 93(1):25-31. PMID: 26519646.
      View in: PubMed
    8. Balkus JE, Nair G, Montgomery ET, Mishra A, Palanee-Phillips T, Ramjee G, Panchia R, Selepe P, Richardson BA, Chirenje Z, Marrazzo JM. Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial. J Acquir Immune Defic Syndr. 2015 Oct 1; 70(2):212-7. PMID: 26049280; PMCID: PMC4573287 [Available on 10/01/16].
    9. Dai JY, Hendrix CW, Richardson BA, Kelly C, Marzinke M, Chirenje Z, Marrazzo JM, Brown ER. Pharmacological Measures of Treatment Adherence and Risk of HIV Infection in the VOICE Study. J Infect Dis. 2016 Feb 1; 213(3):335-42. PMID: 26123563.
      View in: PubMed
    10. Mgodi NM, Kelly C, Gati B, Greenspan S, Dai JY, Bragg V, Livant E, Piper JM, Nakabiito C, Magure T, Marrazzo JM, Chirenje Z, Riddler SA. Factors associated with bone mineral density in healthy African women. Arch Osteoporos. 2015; 10:206. PMID: 25680424; PMCID: PMC4564062 [Available on 02/14/16].
    11. Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L, Hendrix CW, Dai JY, Ganesh S, Mkhize B, Taljaard M, Parikh UM, Piper J, Mâsse B, Grossman C, Rooney J, Schwartz JL, Watts H, Marzinke MA, Hillier SL, McGowan IM, Chirenje Z. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015 Feb 5; 372(6):509-18. PMID: 25651245; PMCID: PMC4341965.
    12. Gomani P, Matubu AT, Mujuru HA, Munjoma MW, Tinago W, Mandozana G, Hakim JG, Gomo ZA, Chirenje Z. Hematological and biochemical laboratory reference intervals for Zimbabwean adolescents. Clin Lab. 2015; 61(1-2):101-11. PMID: 25807644.
      View in: PubMed
    13. Chokunonga E, Borok MZ, Chirenje Z, Nyakabau AM, Parkin DM. Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010. Int J Cancer. 2013 Aug 1; 133(3):721-9. PMID: 23364833.
      View in: PubMed
    14. Dezzutti CS, Richardson BA, Marrazzo JM, Tugetman J, Ramjee G, Taha T, Chirenje Z, Abdool Karim SS, Hillier SL, Herold BC. Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. J Infect Dis. 2012 Dec 15; 206(12):1931-5. PMID: 22966121; PMCID: PMC3502373.
    15. Chirenje Z, Mâsse BR, Maslankowski LA, Ramjee G, Coletti AS, Tembo TN, Magure TM, Soto-Torres L, Kelly C, Hillier S, Karim A. Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel. J Int AIDS Soc. 2012; 15(2):17376. PMID: 22944480; PMCID: PMC3494172.
    16. Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje Z, Taha T, Kapina M, Maslankowski L, Coletti A, Profy A, Moench TR, Piwowar-Manning E, Mâsse B, Hillier SL, Soto-Torres L. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS. 2011 Apr 24; 25(7):957-66. PMID: 21330907; PMCID: PMC3083640.
    17. Chokunonga E, Borok MZ, Chirenje Z, Nyabakau AM, Parkin DM. Cancer survival in Harare, Zimbabwe, 1993-1997. IARC Sci Publ. 2011; (162):249-55. PMID: 21675430.
      View in: PubMed
    18. Chirenje Z, Marrazzo J, Parikh UM. Antiretroviral-based HIV prevention strategies for women. Expert Rev Anti Infect Ther. 2010 Oct; 8(10):1177-86. PMID: 20954882; PMCID: PMC4381115.
    19. Kurewa NE, Munjoma MM, Chirenje Z, Rusakaniko S, Hussain A, Stray-Pedersen B. Compliance and loss to follow up of HIV negative and positive mothers recruited from a PMTCT programme in Zimbabwe. Cent Afr J Med. 2007 May-Aug; 53(5-8):25-30. PMID: 20355678.
      View in: PubMed
    20. Israel-Ballard KA, Maternowska MC, Abrams BF, Morrison P, Chitibura L, Chipato T, Chirenje Z, Padian NS, Chantry CJ. Acceptability of heat treating breast milk to prevent mother-to-child transmission of human immunodeficiency virus in Zimbabwe: a qualitative study. J Hum Lact. 2006 Feb; 22(1):48-60. PMID: 16467287.
      View in: PubMed
    21. Chirenje Z. HIV and cancer of the cervix. Best Pract Res Clin Obstet Gynaecol. 2005 Apr; 19(2):269-76. PMID: 15778115.
      View in: PubMed
    22. Njoroge B, Chirenje Z, Pandey B, Mirembe F, Joshi S, Low-Beer N, Maslankowski LA. The CONRAD/WHO Update 2000 colposcopy manual: how well is it working? J Acquir Immune Defic Syndr. 2004 Oct; 37 Suppl 3:S150-1. PMID: 16419263.
      View in: PubMed
    23. Mbizvo ME, Musya SE, Stray-Pedersen B, Chirenje Z, Hussain A. Bacterial vaginosis and intravaginal practices: association with HIV. Cent Afr J Med. 2004 May-Jun; 50(5-6):41-6. PMID: 15881309.
      View in: PubMed
    24. Chokunonga E, Ramanakumar AV, Nyakabau AM, Borok MZ, Chirenje Z, Sankila R, Parkin DM. Survival of cervix cancer patients in Harare, Zimbabwe, 1995-1997. Int J Cancer. 2004 Mar 20; 109(2):274-7. PMID: 14750180.
      View in: PubMed
    25. Chirenje Z, Rusakaniko S, Kirumbi L, Ngwalle EW, Makuta-Tlebere P, Kaggwa S, Mpanju-Shumbusho W, Makoae L. Situation analysis for cervical cancer diagnosis and treatment in east, central and southern African countries. Bull World Health Organ. 2001; 79(2):127-32. PMID: 11242819; PMCID: PMC2566349.
    26. Tarwireyi F, Chirenje Z, Rusakaniko S. Cancer of the cervix: knowledge, beliefs and screening behaviours of health workers in Mudzi District in Mashonaland East Province, Zimbabwe. Cent Afr J Med. 2003 Jul-Aug; 49(7-8):83-6. PMID: 15214279.
      View in: PubMed
    27. Chirenje Z, Rusakaniko S, Akino V, Munjoma M, Mlingo M. Effect of HIV Disease in Treatment Outcome of Cervical Squamous Intraepithelial Lesions Among Zimbabwean Women. J Low Genit Tract Dis. 2003 Jan; 7(1):16-21. PMID: 17051039.
      View in: PubMed
    28. Chirenje Z, Loeb L, Mwale M, Nyamapfeni P, Kamba M, Padian N. Association of cervical SIL and HIV-1 infection among Zimbabwean women in an HIV/STI prevention study. Int J STD AIDS. 2002 Nov; 13(11):765-8. PMID: 12437897.
      View in: PubMed
    29. Chirenje Z, Rusakaniko S, Akino V, Mlingo M. A randomised clinical trial of loop electrosurgical excision procedure (LEEP) versus cryotherapy in the treatment of cervical intraepithelial neoplasia. J Obstet Gynaecol. 2001 Nov; 21(6):617-21. PMID: 12521783.
      View in: PubMed
    30. Chirenje Z. Topical vaginal microbicides in HIV/STI prevention. Cent Afr J Med. 2001 Aug; 47(8):209-10. PMID: 12808769.
      View in: PubMed
    31. Mbizvo EM, Msuya SE, Stray-Pedersen B, Sundby J, Chirenje Z, Hussain A. Determinants of reproductive tract infections among asymptomatic women in Harare, Zimbabwe. Cent Afr J Med. 2001 Mar; 47(3):57-64. PMID: 11961859.
      View in: PubMed
    32. Ngwalle EW, Mgaya HN, Mpanju-Shumbusho W, Chirenje Z, Kirumbi L, Lebelle T, Kaggwa S. Situational analysis for diagnosis and treatment of cervical cancer in mainland Tanzania. East Afr Med J. 2001 Feb; 78(2):60-4. PMID: 11682947.
      View in: PubMed
    33. Blumenthal PD, Gaffikin L, Chirenje Z, McGrath J, Womack S, Shah K. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int J Gynaecol Obstet. 2001 Jan; 72(1):47-53. PMID: 11146077.
      View in: PubMed
    34. van De Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, Kumwenda N, Chirenje Z, Joshi S, Taha T, Padian N, Bollinger R, Nelson K. Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. J Acquir Immune Defic Syndr. 2001 Jan 1; 26(1):21-7. PMID: 11176265.
      View in: PubMed
    35. Chirenje Z. The management of cervical intra-epithelial neoplasia. Cent Afr J Med. 2000 Nov; 46(11):309-10. PMID: 12002122.
      View in: PubMed
    36. Chirenje Z, Rusakaniko S, Akino V, Mlingo M. A review of cervical cancer patients presenting in Harare and Parirenyatwa Hospitals in 1998. Cent Afr J Med. 2000 Oct; 46(10):264-7. PMID: 11682933.
      View in: PubMed
    37. van de Wijgert JH, Chirenje Z, Iliff V, Mbizvo MT, Mason PR, Gwanzura L, Shiboski S, Padian NS. Effect of intravaginal practices on the vaginal and cervical mucosa of Zimbabwean women. J Acquir Immune Defic Syndr. 2000 May 1; 24(1):62-7. PMID: 10877497.
      View in: PubMed
    38. van De Wijgert JH, Mason PR, Gwanzura L, Mbizvo MT, Chirenje Z, Iliff V, Shiboski S, Padian NS. Intravaginal practices, vaginal flora disturbances, and acquisition of sexually transmitted diseases in Zimbabwean women. J Infect Dis. 2000 Feb; 181(2):587-94. PMID: 10669342.
      View in: PubMed
    39. Womack SD, Chirenje Z, Gaffikin L, Blumenthal PD, McGrath JA, Chipato T, Ngwalle S, Munjoma M, Shah KV. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer. 2000 Jan 15; 85(2):206-10. PMID: 10629079.
      View in: PubMed
    40. Womack SD, Chirenje Z, Blumenthal PD, Gaffikin L, McGrath JA, Chipato T, Ngwalle E, Shah KV. Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe. BJOG. 2000 Jan; 107(1):33-8. PMID: 10645859.
      View in: PubMed
    41. Chirenje Z, Chipato T, Kasule J, Rusakaniko S. Visual inspection of the cervix as a primary means of cervical cancer screening: results of a pilot study. Cent Afr J Med. 1999 Feb; 45(2):30-3. PMID: 10444896.
      View in: PubMed
    42. Chirenje Z, Rusakaniko S, Chipato T, Mpanju-Shumbusho W, Ngwalle E, Kirumbi LW, Makuta-Tlebere P, Kaggwa S. Situation analysis for cervical cancer diagnosis and treatment in Zimbabwe. Cent Afr J Med. 1998 Dec; 44(12):307-10. PMID: 10921202.
      View in: PubMed
    43. Thistle PJ, Chirenje Z. Cervical cancer screening in a rural population of Zimbabwe. Cent Afr J Med. 1997 Sep; 43(9):246-51. PMID: 9509642.
      View in: PubMed
    44. Chirenje Z. Management of the patient with an abnormal Papanicolaou smear. Cent Afr J Med. 1994 May; 40(5):131-4. PMID: 7954725.
      View in: PubMed
    45. Chirenje Z, Akino V. Screening for cervical cancer: experience from the Colposcopy Clinic at Harare Hospital. Cent Afr J Med. 1993 Nov; 39(11):222-4. PMID: 8055551.
      View in: PubMed
    Zvavahera's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP